Showing 1 - 11 results of 11 for search 'Valeria Bertagnolo', query time: 0.04s Refine Results
  1. 1
    Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches

    Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches by Silvia Grassilli, Valeria Bertagnolo, Federica Brugnoli

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer

    Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer by Silvia Grassilli, Federica Brugnoli, Rossano Lattanzio, Simonetta Buglioni, Valeria Bertagnolo

    Published 2020-09-01
    Get full text
    Article
  3. 3
    Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype

    Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype by Silvia Grassilli, Federica Brugnoli, Stefano Cairo, Nicoletta Bianchi, Jean-Gabriel Judde, Valeria Bertagnolo

    Published 2022-06-01
    Get full text
    Article
  4. 4
    Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC

    Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNB... by Federica Brugnoli, Silvia Grassilli, Paola Lanuti, Marco Marchisio, Yasamin Al-Qassab, Federica Vezzali, Silvano Capitani, Valeria Bertagnolo

    Published 2017-09-01
    Get full text
    Article
  5. 5
    Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome

    Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome by Silvia Grassilli, Federica Brugnoli, Rossano Lattanzio, Marco Marchisio, Letizia Perracchio, Mauro Piantelli, Alberto Bavelloni, Silvano Capitani, Valeria Bertagnolo

    Published 2018-06-01
    Get full text
    Article
  6. 6
    The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma

    The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma by Francesca Crudele, Nicoletta Bianchi, Annalisa Astolfi, Silvia Grassilli, Federica Brugnoli, Anna Terrazzan, Valeria Bertagnolo, Massimo Negrini, Antonio Frassoldati, Stefano Volinia

    Published 2021-08-01
    Get full text
    Article
  7. 7
    The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2

    The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2 by Nicoletta Bianchi, Federica Brugnoli, Silvia Grassilli, Karine Bourgeois, Jeffrey W. Keillor, Carlo M. Bergamini, Gianluca Aguiari, Stefano Volinia, Valeria Bertagnolo

    Published 2021-11-01
    Get full text
    Article
  8. 8
    The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO

    The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO by Paola Tedeschi, Federica Brugnoli, Stefania Merighi, Silvia Grassilli, Manuela Nigro, Martina Catani, Stefania Gessi, Valeria Bertagnolo, Alessia Travagli, Maria Fiorenza Caboni, Alberto Cavazzini

    Published 2023-02-01
    Get full text
    Article
  9. 9
    UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines

    UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines by Fabio Corrà, Francesca Crudele, Federica Baldassari, Nicoletta Bianchi, Marco Galasso, Linda Minotti, Chiara Agnoletto, Gianpiero Di Leva, Federica Brugnoli, Eva Reali, Valeria Bertagnolo, Andrea Vecchione, Stefano Volinia

    Published 2021-12-01
    Get full text
    Article
  10. 10
    A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K<sup>+</sup> Channel in Breast Cancer

    A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K<sup>+</sup> Channel in Breast Cancer by Rita Canella, Federica Brugnoli, Mariana Gallo, Jeffrey W. Keillor, Anna Terrazzan, Elena Ferrari, Silvia Grassilli, Eric W. J. Gates, Stefano Volinia, Valeria Bertagnolo, Nicoletta Bianchi, Carlo M. Bergamini

    Published 2022-12-01
    Get full text
    Article
  11. 11
    Imidazo[1,2-<i>b</i>]pyrazole-7-Carboxamide Derivative Induces Differentiation-Coupled Apoptosis of Immature Myeloid Cells Such as Acute Myeloid Leukemia and Myeloid-Derived Suppressor Cells

    Imidazo[1,2-<i>b</i>]pyrazole-7-Carboxamide Derivative Induces Differentiation-Coupled Apoptosis of Immature Myeloid Cells Such as Acute Myeloid Leukemia and Myeloid-Derived Suppre... by Edit Kotogány, József Á. Balog, Lajos I. Nagy, Róbert Alföldi, Valeria Bertagnolo, Federica Brugnoli, András Demjén, Anita K. Kovács, Péter Batár, Gabriella Mezei, Renáta Szabó, Iván Kanizsai, Csaba Varga, László G. Puskás, Gábor J. Szebeni

    Published 2020-07-01
    Get full text
    Article

Search Tools: